A framework for genomic biomarker actionability and its use in clinical decision making

The increasing scope and availability of genetic testing options for patients suffering from cancer has raised questions about how to use results of molecular diagnostics to inform patient care. For some biomarkers (e.g. BRAF mutations in melanoma), standards exist that outline treatments for indivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Vidwans, Smruti J., Turski, Michelle L., Janku, Filip, Garrido-Laguna, Ignacio, Munoz, Javier, Schwab, Richard, Subbiah, Vivek, Rodon, Jordi, Kurzrock, Razelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278279/
https://www.ncbi.nlm.nih.gov/pubmed/25593991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278279/
https://www.ncbi.nlm.nih.gov/pubmed/25593991

Ejemplares similares